Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia
Clinical trial NCT02779283 · COMPLETED
Trial details
- NCT number
- NCT02779283
- Sponsor
- OHSU Knight Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-13
- Primary completion
- 2018-04-19
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.